Navigation Links
Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
Date:6/17/2013

ST. PAUL, Minn., June 17, 2013 /PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency, Weber Shandwick, and branding and design agency, Larsen, was awarded the Silver Anvil for its internal communication campaign "Millions of Reasons, One Purpose, Repositioning Prime Therapeutics." The award was presented at the Public Relations Society of America (PRSA) 2013 Silver Anvil Awards Ceremony held June 13 at the AXA Equitable Center in New York.

The Silver Anvil, which has been presented annually since 1946, is the oldest and one of the most prestigious awards competitions for outstanding achievement in public relations, based on its rigorous judging criteria and emphasis on measurement and evaluation.

"This Silver Anvil award recognizes work we undertook to simplify and redefine our purpose statement to clearly reflect the important work we do to help people get the medicine they need to feel better and live well," said Michael Showalter, chief marketing officer at Prime. "Our employees have embraced this new purpose statement because it focuses on the people we truly serve."

PRSA, which is based in New York, is the largest professional organization serving the U.S. public relations community. With a mission to "advance the profession and the professional," PRSA provides news and information, thought leadership, continuing education and networking opportunities. It also sets standards of professional excellence and advocates for the business value of public relations.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 20 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation. 

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tras el exitoso lanzamiento en Estados Unidos, el nuevo Simbionix U/S Mentor se introducirá por primera vez en Europa
2. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
3. Prime Therapeutics specialty pharmacy receives URAC accreditation
4. Zydus Demonstra Pioneirismo com o Inovador LIPAGLYN, Primeiro NCE da Índia a Entrar no Mercado
5. Prime Therapeutics appoints Scott Fries as senior vice president of government programs
6. Primex Wireless Adds Differential Pressure Monitoring to IAQ lineup with Release of SNS Application Management Platform (AMP 4.0)
7. Journal of Managed Care Pharmacy recognizes Prime Therapeutics with two 2012 JMCP Award for Excellence Honorable Mentions
8. Sanomedics Signs Definitive Agreement to Acquire Prime Time Medical
9. PrimerLife.com celebra el aniversario del descubrimiento del ADN con una nueva red social
10. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
11. Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
(Date:3/27/2017)...  Twist Bioscience, a company accelerating science and innovation ... raised an additional $33 million. To date, Twist Bioscience ... "It is an exciting time to be leading ... to deliver industry-leading gene volume to our customers, enabling ... Leproust, Ph.D., CEO of Twist Bioscience. "We welcome the ...
(Date:3/27/2017)... , March 27, 2017   Genprex, Inc. , a ... Julien Pham , MD, the Company,s Chief Operating Officer, is ... conferences. Sachs 5th Annual Cancer BioPartnering & Investment ... New York, NY ... BioCentury 24th Annual Future Leaders in Biotech ...
Breaking Medicine Technology:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... the organization behind the New England Journal of Medicine and NEJM Journal Watch, ... Knowledge+ Pediatrics Board Review was created by a panel of pediatricians from leading ...
(Date:3/27/2017)... ... 27, 2017 , ... Osteitis pubis may be commonplace and ... it occurs when the muscles around the pelvis become inflamed. Over time, untreated ... torso, as well as accompanying tenderness and weakness. Without proper intervention, it can ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... announce that for a second year in a row; they are the recipient ... designers in the industry voted on the award at Design Connections 2017. Top ...
(Date:3/27/2017)... ... , ... The Anaheim Hills office accelerates and supports FNCC’s growth and further ... sales professionals over the past 6 months and is continuing to recruit new talent ... course of 2017. , “This new office is a direct result of our ...
(Date:3/27/2017)... ... 27, 2017 , ... Golden Triangle Emergency Center will be ... 3rd to commemorate the two-year anniversary of the facility. The event will feature ... great years while also familiarizing themselves with the facility. , In the two ...
Breaking Medicine News(10 mins):